Immediate removal of mandatory weight measurements via digital scales as a condition for accessing GLP-1 therapies, and clarification on how any weight data collected will be used, stored, and reported
Across GLP-1based therapies, gastrointestinal adverse effects remain the most commonly reported limitation
331(b)
Science is proving again and again that the old, simplistic model of calorie-in, calorie-out simply does not work for most women, especially as we age, which is why even the most restrictive diets often end up with rebound weight gain
Broader Social and Community Concerns We are also witnessing a troubling cultural normalization and commercialization of GLP-1s: Advertisements for GLP-1 medications appear in community media, unlike other controlled or potentially addictive substances
Proper syringe disposal Used syringes go in a puncture-resistant sharps container